University of Baghdad Launches Ivermectin Clinical Trial for COVID-19 Patients

University of Baghdad Launches Ivermectin Clinical Trial for COVID-19 Patients

The valley where the Tigris and Euphrates Rivers flows down through what is now modern-day Iraq is literally a cradle of Civilization. After all, the world’s first writing occurs here in the form of cuneiform—the language of ancient Mesopotamia. Iraq’s University of Baghdad is the Arab’s world’s second largest university, and by some accounts got it’s start in 1067 AD as Abu-Haneefa. Regardless, its modern form materialized as the College of Law in 1908, and a College of Medicine launched in 1927. In 2020, the university was listed in the Times Higher Education World University Rankings. Recently the College of Medicine’s research arm launched a clinical trial to assess the safety and efficacy of adjuvant use of Ivermectin in Covid-19 patients with Pneumonia.

Is there something to this Ivermectin and COVID-19?

TrialSite News has been monitoring the use of Ivermectin around the globe—starting with the University of Monash findings in a laboratory cell culture experiment. Then MedinCell, a French biotech company, commenced an Ivermectin research program centering on COVID-19; in parallel, a physician in Broward County Florida received official approval from a local health boar...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee